Clinical Trials
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG) (CTMS# 22-0089)
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Anne–Marie Langevin MD